PeterGuyCardielloMD

PubMed

• 16 citations
  Strengthening Healthcare Capacity Through a Responsive, Country- Specific, Training Standard: The KITSO AIDS Training Program's Sup- port of Botswana's National Antire...
  Christine Bussmann, Philip Rotz, Ndwapi Ndwapi, Daniel Baxter, Hermann Bussmann, C. William Wester, Patricia Ncube, Ava Avalos, Madisa Mine, Elang Mabe, Patricia J Bur...> ;The Open AIDS Journal. 2008 Feb 29
• 102 citations
  Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.
  Marlink, R., C. William Wester, Soyeon Kim, Hermann Bussmann, Ava Avalos, Ndwapi Ndwapi, Trevor Peter, Tendani Gaolathe, Andrew Mujugira, Lesego Busang, Chris Vanderwa...> ;Journal of Acquired Immune Deficiency Syndromes. 2005 Nov 1
• 31 citations
  Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous ...
  Jintanat Ananworanich, Umaporn Siangphoe, Andrew F. Hill, Peter Cardiello, Wichitra Apateerapong, Bernard Hirschel, Apicha Mahanontharit, Sasiwimol Ubolyam, David A. C...> ;Journal of Acquired Immune Deficiency Syndromes. 2005 Aug 15
• 28 citations
  Establishment of a Public Antiretroviral Treatment Clinic for Adults in Urban Botswana: Lessons Learned
  C. William Wester, Hermann Bussmann, Ava Avalos, Ndwapi Ndwapi, Tendani Gaolathe, Peter Cardiello, Christine Bussmann, Howard Moffat, Patson Mazonde, Marlink, R., Rich...> ;Clinical Infectious Diseases. 2005 Apr 1
• 11 citations
  The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
  Peter Cardiello, Preeyaporn Srasuebkul, Elly A. M. Hassink, Apicha Mahanontharit, Tarika Samor, Kiat Ruxrungtham, J. M. A. Lange, David A. Cooper, Praphan Phanuphak> ;HIV Medicine. 2005 Mar 1
• 57 citations
  A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection
  Peter Cardiello, Elly A. M. Hassink, Jintanat Ananworanich, Preeyaporn Srasuebkul, Tarika Samor, Apicha Mahanontharit, Kiat Ruxrungtham, Bernard Hirschel, Joep M. A. L...> ;Clinical Infectious Diseases. 2005 Feb 15
• 64 citations
  Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs.
  Jintanat Ananworanich, Zewlan Moor, Umaporn Siangphoe, Jason Chan, Peter Cardiello, Chris Duncombe, Praphan Phanuphak, Kiat Ruxrungtham, Joep M. A. Lange, David A. Cooper> ;AIDS. 2005 Jan 28
• 23 citations
  Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients.
  Marlink, R., Florence Doualla-Bell, S Gaseitsiwe, Thumbi Ndung'u, Musetsanagepe Modukanele, Trevor Peter, Vladimir Novitsky, Ndwapi Ndwapi, Gaolathe Tendani, Ava Avalo...> ;Antiviral Chemistry & Chemotherapy. 2004 Aug 1
• 9 citations
  Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.
  Chaiwat Ungsedhapand, Preeyaporn Srasuebkul, Peter Cardiello, Kiat Ruxrungtham, Winai Ratanasuwan, Eugene Kroon, Metta Tongtalung, Nittaya Juengprasert, Sasiwimol Ubol...> ;Journal of Acquired Immune Deficiency Syndromes. 2004 Jun 1
• 10 citations
  Pharmacokinetics of lower doses of saquinavir soft-gel caps (800 and 1200 mg twice daily) boosted with itraconazole in HIV-1-positive patients.
  Peter Cardiello, Tarika Samor, David M. Burger, Richard M. W. Hoetelmans, Apicha Mahanontharit, Kiat Ruxrungtham, Joep M. A. Lange, David A. Cooper, Praphan Phanuphak> ;Antiviral Therapy. 2003 Jun 1
• 33 citations
  Pharmacokinetics of once-daily saquinavir hard-gelatin capsules and saquinavir soft-gelatin capsules boosted with ritonavir in HIV-1-infected subjects.
  Peter Cardiello, Tarkika Monhaphol, Apicha Mahanontharit, Rolf P. G. van Heeswijk, David M. Burger, Andrew F. Hill, Kiat Ruxrungtham, Joep M. A. Lange, David A. Cooper...> ;Journal of Acquired Immune Deficiency Syndromes. 2003 Apr 1
• 48 citations
  Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study.
  Peter Cardiello, Rolf P. G. van Heeswijk, Elly A. M. Hassink, Preeyaporn Srasuebkul, Apicha Mahanontharit, Tarika Samor, Wassana Worarien, Jos H. Beijnen, Richard M. W...> ;Journal of Acquired Immune Deficiency Syndromes. 2002 Apr 15
• Join now to see all